Clinical Trial Update: A Study of DA-8159 in Subjects With Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial of DA-8159 for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• DA-8159

Snippet

Sponsor: Dong-A PharmTech Co., Ltd. | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED